Articles
-
USC Schaeffer Collaborates with L.A. City and County to Explore Use of Rapid COVID-19 Testing
Researchers are evaluating rapid antigen tests with first responders who volunteered for the study. A second phase will focus on school-aged children, teachers and staff.
-
The COVID-19 Vaccines Are Coming. Here’s How They Should Be Rolled Out
Well before Operation Warp Speed delivers products en masse, we need to be prepared to distribute them effectively.
Categorized in -
New USC AD-RCMAR Scientists Will Study the Impact of Policy on Vulnerable Aging Populations
Three budding experts have been awarded support for projects aimed at improving the lives of older adults facing Alzheimer’s and dementia.
Categorized in -
USC-Brookings Schaeffer Initiative Receives $3.6 Million from Arnold Ventures to Examine Rising Healthcare Spending
The project will focus on physician consolidation, surprise billing, out-of-pocket spending and policies to address healthcare prices.
Categorized in -
Podcast: Essentially Medicine
Jakub Hlavka discusses numerous approaches to increase access to cell- and gene-therapies and how political will is essential to realize improvements in healthcare on the Essentially Medicine podcast.
Categorized in -
For the Sake of Kidney Patients, Vote No on Proposition 23
As a kidney doctor and health policy researcher, I am appalled that patients have become a bargaining chip in a game that could result in massive dialysis shortages, increased costs, and death.
Categorized in -
Applying to be a USC-AD RCMAR Scientist
Since 2012, the Schaeffer Center has received $6.1 million in funding from the NIH to fund pilot projects by junior scholars focused on addressing disparities. This year we are seeking junior scientists concentrating on Alzheimer’s disease and related dementias in minority populations.
Categorized in -
Surprise Medical Bills Increase Costs for Everyone, Not Just for the People Who Get Them
About 12% of insurers’ U.S. spending on in- and out-of-network medical care goes to six types of providers that commonly submit surprise bills.
-
BMJ: What Current and Missing Data Can Teach Us About Medication Errors
The cost of medication errors worldwide exceeds $42 billion, or approximately 5%–6% of all hospitalizations. There are a number of cost-effective strategies that could be deployed to reduce the quantity of adverse drug events.
Categorized in -
NEJM: Competing Visions for the Future of Health Policy
Beyond Covid-19, two other health policy issues are poised to feature prominently in the 2020 U.S. elections: what role government should play in ensuring broad health insurance coverage, and how to cope with the lack of competition in many health care provider markets.